HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masanori Ikeda Selected Research

Transcription Factors (Transcription Factor)

1/2017Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones.
2/2005Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masanori Ikeda Research Topics

Disease

27Infections
01/2024 - 11/2002
20Chronic Hepatitis C
01/2017 - 05/2005
19Hepatocellular Carcinoma (Hepatoma)
08/2018 - 08/2007
8Asthma (Bronchial Asthma)
03/2024 - 01/2013
8Inflammation (Inflammations)
08/2022 - 12/2011
5Atopic Dermatitis (Atopic Eczema)
12/2023 - 03/2022
5Hepatitis C
09/2018 - 10/2007
5Neoplasms (Cancer)
09/2013 - 02/2002
4Anemia
03/2022 - 05/2005
3Virus Diseases (Viral Diseases)
10/2019 - 08/2007
3Chronic Hepatitis (Chronic Active Hepatitis)
09/2013 - 11/2002
3Melanoma (Melanoma, Malignant)
05/2009 - 08/2007
2Food Hypersensitivity (Food Allergy)
01/2024 - 01/2012
2Anaphylaxis (Anaphylactic Shock)
01/2024 - 01/2017
2Airway Remodeling
08/2022 - 01/2022
2T-Cell Leukemia (Leukemia, T Cell)
03/2019 - 12/2015
2Seizures (Absence Seizure)
01/2019 - 01/2018
2Brain Diseases (Brain Disorder)
01/2019 - 01/2018
2Liver Cirrhosis (Hepatic Cirrhosis)
08/2018 - 09/2013
2Fibrosis (Cirrhosis)
01/2017 - 07/2011
2Exanthema (Rash)
05/2014 - 01/2013
2Ageusia (Hypogeusia)
05/2014 - 01/2013
2Ulcer
02/2012 - 07/2011
1Eosinophilic Esophagitis
12/2023
1Eosinophilia
12/2023
1Duodenal Ulcer (Curling's Ulcer)
12/2023
1Eosinophilic enteropathy
12/2023
1Acne Vulgaris
08/2023
1Skin Diseases (Skin Disease)
01/2023
1Chronic Obstructive Pulmonary Disease (COPD)
08/2022
1Neutropenia
03/2022
1Herpes Zoster
03/2022
1Genomic Instability
01/2022
1Diarrhea
11/2021
1Pneumococcal Infections
10/2021
1Body Weight (Weight, Body)
11/2019
1Chronic Hepatitis B
10/2019

Drug/Important Bio-Agent (IBA)

19InterferonsIBA
10/2019 - 10/2004
16Proteins (Proteins, Gene)FDA Link
06/2018 - 03/2003
13Ribavirin (Virazole)FDA LinkGeneric
01/2017 - 05/2005
10Antiviral Agents (Antivirals)IBA
10/2019 - 02/2005
9RNA (Ribonucleic Acid)IBA
06/2018 - 10/2010
7Indicators and Reagents (Reagents)IBA
01/2017 - 11/2002
5Adrenal Cortex Hormones (Corticosteroids)IBA
08/2023 - 01/2018
4Janus Kinase InhibitorsIBA
12/2023 - 03/2022
4upadacitinibIBA
12/2023 - 03/2022
4Phosphotransferases (Kinase)IBA
11/2014 - 02/2005
3C-Reactive ProteinIBA
12/2023 - 08/2003
3CytokinesIBA
08/2022 - 07/2003
3Renilla LuciferasesIBA
08/2018 - 04/2011
3Biomarkers (Surrogate Marker)IBA
01/2018 - 05/2010
2Monoclonal AntibodiesIBA
03/2024 - 12/2023
2Epinephrine (Adrenaline)FDA LinkGeneric
01/2024 - 01/2017
2SteroidsIBA
12/2023 - 08/2022
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2016
2Green Fluorescent ProteinsIBA
06/2021 - 01/2007
2Tacrolimus (Prograf)FDA LinkGeneric
07/2020 - 12/2019
2EmollientsIBA
07/2020 - 12/2019
2Ointments (Pastes)IBA
07/2020 - 12/2019
2ProcalcitoninIBA
01/2019 - 01/2018
2Transcription Factors (Transcription Factor)IBA
01/2017 - 02/2005
2N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
05/2014 - 01/2013
2telaprevirIBA
05/2014 - 01/2013
2Interferon-alpha (Interferon Alfa)IBA
09/2013 - 04/2008
2tulobuterolIBA
03/2013 - 01/2013
2Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
03/2013 - 01/2013
2geranylgeranylacetone (teprenone)IBA
02/2012 - 07/2011
2MicroRNAs (MicroRNA)IBA
07/2011 - 05/2010
2Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2009 - 08/2007
2Serine Proteases (Serine Protease)IBA
01/2009 - 02/2005
2Toll-Like Receptors (Toll-Like Receptor)IBA
08/2007 - 02/2005
2LactoferrinIBA
01/2007 - 11/2002
2Amino AcidsFDA Link
01/2007 - 03/2003
1benralizumabIBA
03/2024
1vidofludimusIBA
01/2024
1Immunoglobulin E (IgE)IBA
12/2023
1dupilumabIBA
12/2023
1ChemokinesIBA
12/2023
1Janus KinasesIBA
08/2023
1Creatine Kinase (Creatine Phosphokinase)IBA
03/2022
1Omalizumab (Xolair)FDA Link
01/2022
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2022
1Anti-Bacterial Agents (Antibiotics)IBA
11/2021
1AllergensIBA
11/2021
1Environmental Pollutants (Pollutants, Environmental)IBA
11/2021
1TanninsIBA
11/2021
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
10/2021
1Conjugate VaccinesIBA
10/2021
1Lysosomal-Associated Membrane Protein 1IBA
06/2021
1Red Fluorescent ProteinIBA
06/2021
1mepolizumabIBA
11/2019
1Phospholipid Transfer ProteinsIBA
10/2019
1NucleotidesIBA
10/2019
1NucleosidesIBA
10/2019
1Polysaccharides (Glycans)IBA
03/2019
1ascophyllinIBA
03/2019

Therapy/Procedure

23Therapeutics
08/2022 - 07/2004
2Drug Therapy (Chemotherapy)
02/2002 - 01/2002
1Subcutaneous Injections
12/2023
1Biological Therapy
08/2022